| Literature DB >> 32345064 |
Lorenzo Guglielmetti1,2,3, Marcus Low4,5,6, Lindsay McKenna5,7.
Abstract
Entities:
Keywords: EMA; FDA; MDR-TB; Tuberculosis; WHO; XDR-TB; clinical trial; drug resistance; new drug
Mesh:
Substances:
Year: 2020 PMID: 32345064 DOI: 10.1080/14787210.2020.1756776
Source DB: PubMed Journal: Expert Rev Anti Infect Ther ISSN: 1478-7210 Impact factor: 5.091